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Abstract 
Background: Shoulder pain and loss of function are directly associated with obesity.
Questions/purposes: We hypothesized that significant interactions would exist between total shoulder arthroplasty 
(TSA) and reverse total shoulder arthroplasty (RSA) and obesity status on functional and quality of life (QOL) outcomes 
over the long term. Clinical and QOL outcomes (American Shoulder and Elbow Surgeons Evaluation form, Shoul-
der Pain and Disability Index, University of California at Los Angeles Shoulder Rating scale, Medical Outcomes Short 
Form 12 (SF-12), range of motion (ROM), and strength) were longitudinally compared in patients with low and high 
body mass index (BMI) after a TSA or a RSA. Prospectively collected data of patients with a TSA or RSA were reviewed 
(N = 310). Preoperative, 2-year, and final follow-up visits were included (range 3–17 years; mean 5.0 ± 2.5 years). 
Patient data were stratified for analysis using BMI.
Results: Morbidly obese patients had worse preoperative functional scores and QOL compared to the other groups. 
There were no significant interactions of BMI group by surgery type for any of the outcome variables except for active 
external rotation ROM. Morbidly obese patients attained lower SF-12 scores compared to the remaining groups at 
each time point.
Conclusions: Both TSA and RSA can be expected to impart positive functional outcomes in patients irrespective of 
BMI. Morbidly obese patients do not attain the same gains in Medical Outcomes SF-12 scores as the non-morbidly 
obese patients. The lower improvements in active external ROM may be due to morphological limitations of excessive 
adiposity.
Level of evidence: This is a level II study.
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Background
Shoulder pain and loss of function are directly associ-
ated with obesity (Kane et  al. 2010). High body mass 
index (BMI) increases incidence of rotator cuff tendini-
tis (Wendelboe et al. 2004), arthropathy, rotator cuff tear 
size (Gumina et al. 2014), and the need for elective shoul-
der replacement (Bostman 1994). The annual volume 
of total shoulder arthroplasty (TSA) and reverse total 
shoulder arthroplasty (RSA) has increased 2.5 fold in the 
U.S. from 2000 to 2008 (Beck et al. 2013; Bostman 1994). 
The percentage of overweight and obese patients under-
going TSA or RSA ranges from 19 to 75% (Gupta et  al. 
2014) depending on the cohort (Gupta et al. 2014; Wer-
ner et al. 2015b). TSAs and RSAs are often indicated for 
treatment of osteoarthritis of the shoulder. RSAs are typi-
cally indicated for rotator cuff tear arthropathy, massive 
rotator cuff tears, proximal humerus fractures, revision 
arthroplasty, and glenohumeral osteoarthritis in the con-
text of irreparable rotator cuff tears (Saltzman et al. 2014) 
and the indications for use are continuing to expand 
(Urch et al. 2016).
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The relationship between BMI and shoulder replace-
ment outcome is complex. High BMI increases the 
surgical complexity and risk for complications out to 
6 months (Beck et al. 2013; Griffin et al. 2014; Gupta et al. 
2014; Werner et al. 2015a, b), but may not impact 30-day 
complications (Jiang et al. 2016). Obesity does not neces-
sarily inhibit gains in outcome scores and quality of life 
(QOL) over the short-term (Li et  al. 2013). Few studies 
have assessed obesity’s collective impact on pain, range 
of motion (ROM), or QOL after shoulder replacement (Li 
et al. 2013; Linberg et al. 2009; Pappou et al. 2014). Lim-
ited evidence suggests that obese patients can attain sim-
ilar 2-year improvements in physical health as non-obese 
patients after TSA (Li et  al. 2013) and can attain good 
surgical outcomes after RSA (Statz et  al. 2016). What 
remains unclear is whether shoulder-specific outcomes, 
physical function, and patient-reported QOL are differ-
ent beyond 2 years or longer across different BMI strata. 
This evidence gap is significant; comparative patient-cen-
tric metrics are not yet available to facilitate the shared 
decision-making process between patient and surgeon. 
An improved understanding of the mechanics of RSA 
and prostheses permitted the expansion of indications 
that are considered appropriate for this procedure (Urch 
et  al. 2016), thereby increasing the likelihood that its 
use in patients with high BMI values becomes common. 
Moreover, as the indications for the use of RSA expand, 
it is not clear whether obesity differentially impacts these 
actual or patient-reported outcomes over a longer time 
frame.
Previous work has shown that morbidly obese patients 
have significantly worse functional outcomes than non-
obese counterparts after rehabilitation for lower body 
elective procedures such as hip and knee arthroplasty 
(Vincent and Vincent 2008; Vincent et  al. 2007). It is 
still unclear whether mid-term TSA and RSA actual and 
patient-reported outcomes are different based on BMI 
value, which precludes establishment of expected mid-
term elective shoulder replacement outcomes and risk 
analysis. It is possible that despite the different indication 
for TSA and RSA and different initial functional ability, 
obese patients may report similar perceived improve-
ments in QOL as non-obese patients. Clarifying the rela-
tionship of BMI strata to outcomes after TSA and RSA 
will provide the first complete patient experience that 
can be used to establish expectations for improvement in 
patient subgroups that may benefit from additional inter-
ventions. Comparative evidence of sustained outcomes is 
essential as health care moves toward a pay-for-perfor-
mance and value-based system (Li et al. 2013). Thus, our 
study first compared surgery-specific and general health 
QOL outcomes between non-obese, obese, and morbidly 
obese patients with a TSA or RSA. We hypothesized that 
significant interactions would exist between the surgery 
type and obesity status on functional and QOL out-
comes over the long term. Although all patients would 
experience improved functional outcomes and QOL, we 
anticipated that morbidly obese patients would report 
lower QOL and physical function gains than non-obese 
patients after TSA and RSA.
Methods
Study design
A retrospective review was conducted of prospectively 
collected data on patients who underwent TSA or RSA 
between January of 1992 and May of 2012 at the Univer-
sity of Florida. Both TSA and RSA were included in this 
analysis as RSA represents approximately one-third of 
the nationally reported shoulder replacement surgeries 
in the U.S. (Westermann et al. 2015). Diagnoses included 
osteoarthritis, acute fracture, rotator cuff tear, and rota-
tor cuff arthropathy, and other (osteonecrosis, avascular 
necrosis, and synovial chondromatosis).
Of the enrolled patients, 310 had complete follow-
up data for our research questions. Patients underwent 
TSA or RSA and had a minimum 2-year follow up and a 
final mid-term mean follow up of 5.0 ± 2.5 years (range 
3–17 years). Age ranged from 21 to 95 years. Study docu-
ments and procedures were approved by the University 
of Florida Institutional Review Board and procedures 
conformed to the guidelines set by the Declaration of 
Helsinki for the treatment of human subjects.
Patients were stratified into groups based on BMI val-
ues: non-obese (BMI < 30 kg/m2), obese (30–39.9 kg/m2), 
and morbidly obese (≥40  kg/m2) for statistical analysis 
(Kane et  al. 2010). Demographics (age, height, weight, 
BMI, and ethnicity/race), surgery type (TSA or RSA), 
comorbidities, perioperative analgesic use, and tobacco 
use were collected preoperatively.
Patient‑reported outcome measures
Surveys were administered to each participant on subjec-
tive shoulder-specific functional and pain outcomes, per-
ceived physical activity, and general health.
American Shoulder and Elbow Surgeons Evaluation form 
(ASES)
The ASES permits the patient to self-evaluate pain, shoul-
der instability, and activities of daily living (Richards et al. 
1994). Eleven items are used to generate a score (pain 
has one item, function ten items). The physician-assess-
ment section documents ROM, physical signs, strength, 
and stability. The final score is derived from the pain and 
cumulative activities of daily living score (Richards et al. 
1994). A minimal clinically important difference is 6.4 
points (Roy et al. 2009).
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Shoulder Pain and Disability Index (SPADI)
The SPADI assesses shoulder pain and disability in the 
outpatient setting (Breckenridge and McAuley 2011), 
with 13 items categorized into two subscales: pain (five 
items) and disability (eight items) (Roach et  al. 1991). 
This instrument has high internal consistency with 
Chronbach’s α values ranging from 0.86 to 0.95 for the 
subscales. The SPADI responds to change over time 
in various patient populations, and can discriminate 
between patients with improving and deteriorating 
conditions (Beaton and Richards 1996; Roy et  al. 2009; 
Williams et al. 1995). A minimal clinically important dif-
ference is 8 points (Roy et al. 2009).
University of California at Los Angeles Shoulder Rating scale 
(UCLA)
This scale has separate domain areas: pain, function, 
strength of forward flexion, active forward flexion, and 
overall patient satisfaction (Amstutz et  al. 1981). The 
scale is weighted by pain, and function accounts for 20 
points. The other domains account for 15 points, giving 
a total score of 35 points (<27 is poor and fair and >27 
is good to excellent). This has been used in patients with 
shoulder replacement due to osteoarthritis, rotator cuff 
disease, and instability (Kirkley et al. 2003).
Constant score
This score is comprised of subjective assessments relating 
to pain, activities of daily living, and objective measures 
of shoulder motion and strength. The maximum score 
is 100 points, with higher scores representing less pain 
and better shoulder function (Constant et al. 2008). Con-
struct validity is 6 = .673, and the Constant score corre-
lates moderately well with the UCLA score (r =  0.673) 
(Oh et al. 2009).
Medical Outcomes Short Form 12 (SF‑12)
The SF-12 is a standardized, validated health related QOL 
questionnaire comprised of 12 items of the Medical Out-
comes Short Form 36 original instrument (Ware et  al. 
1996). The SF-12 summary score (PCS-12 and MCS-12) 
ranges from 0 to 100 points. The SF-12 has a high test–
retest reliability (r = 0.89) and has been validated for use 
in independently living older adults with chronic illnesses 
(Resnick and Nahm 2001).
Radiological outcomes and adverse events
Development of radiolucency lines during the follow-
up (specifically within the glenoid) and scapular notch-
ing was identified by the surgeon in the study (Choi 
et  al. 2013). Adverse events included infections, bone 
graft failure, loosening, dislocation, rotator cuff failure, 
wound complications, fracture, and pain and stiffness. 
The number of revisions in each surgery category was 
documented. The criteria for revisions included the fol-
lowing: infections, loosening or instability, dislocation, 
bone graft failure, and rotator cuff repair failure. If revi-
sions occurred, the follow-up time was determined from 
the initial procedure.
Objective functional measures
Passive and active shoulder ROM was assessed by an 
experienced athletic trainer using a goniometer. Active 
external rotation and active elevation measures were 
performed by the patient. Each participant lifted pro-
gressively higher weights in increments of 2.2  kg dur-
ing a lateral straight arm raise to estimate strength. The 
strength value was defined as the maximal weight the 
patient could lift with appropriate form once.
Statistical analyses
Data were analyzed using the Statistical Package for the 
Social Sciences (SPSS version 24.0, IBM Corp; Chicago, 
IL). Patient characteristics were compared between the 
three BMI strata (non-obese, overweight, and obese) 
using one-way analysis of variance (ANOVA) and a 
Scheffé post hoc analysis for continuous variables and by 
Kruskal–Wallis tests for categorical variables. Chi square 
tests were used to determine whether distributions of 
the shoulder pain mechanisms, radiolucency lines, and 
scapular notching were different among the groups. To 
address the purposes of the study, generalized linear 
models were used, where the dependent variables were 
study outcomes (ASES, SPADI, UCLA, Constant scores, 
SF-12, range of motion and strength) and the predic-
tors were obesity status (non-obese, obese, and morbidly 
obese) and surgical type (RSA or TSA). Covariates were 
diagnosis and age. Significance was established at p < .05 
a priori for all tests.
Results
Table 1 shows patient characteristics. The morbidly obese 
group had a higher prevalence of women and Diabetes 
Mellitus than the other groups (p < .05). The obese group 
had a greater proportion of patients with hypertension 
and those who took analgesics for pain than the remain-
ing groups (p <  .05). A total of 56.9% of patients under-
went a TSA and 43.1% underwent a RSA. There was a 
significant difference in the distributions of shoulder 
pain mechanisms among the BMI groups (χ2 =  52.417; 
p < .0001).
Adverse events that did and did not require revision are 
shown in Table 2 for the surgery types and BMI groups. 
The numbers of radiolucent lines (humeral and glenoid) 
and scapular notching at follow-ups are shown in Table 3. 
The distributions of the radiolucency lines (glenoid 
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and humeral) and scapular notching were not different 
among the BMI groups. The revision procedures that 
were performed included the following: removal and 
replacement of long-stem humeral implant, revision to 
hemiarthroplasty, removal of loose glenoid and revision, 
conversion of TSA to RSA, reduction and revision, revi-
sion to an antibiotic spacer, and bone grafting for injury 
after a fall.
Patient-reported functional outcomes are provided in 
Table  4. There were no significant interactions of obe-
sity status by time for any outcome variable. There were 
no significant main effects of obesity or surgery type for 
any outcome. Improvements were maintained at the final 
follow-up.
Patient-reported QOL SF-12 scores are presented in 
Table 5. There were no significant interactions of obesity 
status by time for the SF-12 scores. However, there was 
a main effect for obesity for all SF-12 scores (p  <  0.05). 
All BMI groups improved the SF-12 scores over time, but 
the morbidly obese group attained lower SF-12 scores 
compared to the remaining groups at each time point 
(p < .0001).
Objective functional scores of active and passive ROM 
and shoulder strength are presented in Table 6. Only one 
significant obesity status by time interaction existed for 
Table 1 Participant characteristics of the study groups
Values are mean ± SD or percent of the group













Age (years) 69.1 ± 10.4 69.3 ± 8.5 66.9 ± 5.2 0.124
Weight (kg) 73.6 ± 12.4 94.1 ± 13.9 126.2 ± 19.5 0.0001
BMI (kg/m2) 26.1 ± 2.5 34.1 ± 2.9 47.3 ± 5.6 0.0001
Sex (%)
 Male 50 49.5 27
 Female 50 50.5 73 0.002
Ethnicity (%)




 Hispanic 2.3 0.9 0
 Asian 0 0.9 0
 Other 0 1.9 0 0.467
Comorbidities (%)
 Hypertension 23 38.5 30.2 0.0001
 Heart disease 9.3 9.8 4.8 0.436
 Diabetes 
mellitus
9.3 10.2 23.8 0.002
 Tobacco use 
(%)
4.1 3.1 0 0.692
 Analgesic use 
(%)
25.2 36 27 0.004




 Osteoarthritis 43.7 52.9 63.5
 Rotator cuff 
tear
1.3 3.7 4.8
 Rotator cuff 
arthropathy
35.7 30.8 20.6
 Other 15.2 10.8 11.1 0.0001
Table 2 Adverse events (AE) in  patients from  each body 
mass index (BMI) stratum
TSA total shoulder arthroplasty, RSA reverse shoulder arthroplasty, RCR rotator 
cuff repair






AE not requiring revision
TSA (five patients, six AE)
 Loosening 1 0 0
 RCR failure 2 0 0
 Wound complication 0 1 0
 General pain and stiffness 2 0 0
RSA (nine patients, ten AE)
 Fracture 5 4 0
 Dislocation 1 0 0
Revision required <2 years
TSA (seven patients, seven AE)
 Infection 0 1 0
 Loosening 1 0 1
 RCR failure 4 0 0
RSA (five patients, seven AE)
 Infection 2 0 0
 Loosening 1 0 0
 Dislocation/unstable 4a 0 0
Revision required >2 years
TSA (13 patients, 17 AE)
 Infection 3 1 0
 Loosening 5 1 0
 Dislocation/unstable 1 0 0
 Fracture 1 1 0
 Bone graft failure 0 0 0
 RCR failure 3 1 0
RSA (four patients, seven AE)
 Infection 0 1 0
 Loosening 2 1 0
 Fracture 0 1 0
 Bone graft failure 1 0 0
 RCR failure 1 0 0
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active external rotation (p =  .021), with main effects of 
both obesity and surgery type reaching significance.
Discussion
The interactions between surgery type and obesity status 
on several mid-term shoulder-specific general outcomes 
were tested. The novel findings are (a) morbidly obese 
patients made significant improvements in functional 
and QOL outcomes over the mid-term; (b) there were no 
significant main effects for surgery type on ASES, SPADI, 
UCLA, and Constant scores; and (c) shoulder replace-
ment adverse events and radiological outcomes were not 
different among the BMI groups. These findings demon-
strate sustained benefit of both surgery types on clinically 
meaningful outcomes even in patients with high BMIs. 
The magnitude of improvement in QOL was less in the 
morbidly obese patients compared with the remaining 
groups by follow-up.
General health QOL and ROM/strength assessments 
were compared among non-obese, obese, and morbidly 
obese patients. Surgery benefits on outcomes were main-
tained past 2 years, suggesting that shoulder arthroplasty 
effectively relieves symptoms and improves function in 
patients across the BMI spectrum. Because morbidly obese 
patients had worse function and QOL before the surgery, 
they did not achieve the same absolute level of improve-
ment as the other BMI groups on the ASES, SPADI, and 
UCLA scores. Improvements in these outcomes ranged 
from 48 to 65% in the morbidly obese group, and from 60 
to 115% in the other groups. Despite the lesser gain in per-
ceived function, morbidly obese groups achieved similar 
relative improvements in the SF-12 physical component 
score and over twice the improvement in the SF-12 mental 
component score than the other BMI groups. Few directly 
comparable data are available in obese patients. However, 
patient-reported QOL after RSA has been shown to reach 
comparable levels to that of healthy age-matched norms 
using the SF-36. Also, SF-36 domains have been shown 
to be higher than those reported by a normalized age-
matched cohort after TSA (Gruson et al. 2010).
Table 3 Radiolucency lines and scapular notching by the final follow-up time point
Values represent number and patient number (in parentheses)
Non‑obese n Obese Morbidly obese p (sig)
Humeral radiolucent lines visible 7 (seven patients) 5 (five patients) 1 (one patient) 0.999
Glenoid radiolucent lines visible 97 (48) 76 (38) 10 (9) 0.376
Scapular notching 12 (11) 4 (4) 0 (0) 0.580
Table 4 Patient-reported functional outcomes
Values are expressed in points and are shown as mean ± SD. Significance is the interaction of time point by obesity status














 Preoperative 39.5 ± 16.6 36.7 ± 14.8 27.1 ± 10.6
 2 years 80.1 ± 18.0 81.4 ± 18.2 72.3 ± 16.6
 Follow-up 74.8 ± 20.5 78.9 ± 19.8 68.2 ± 23.4 0.114 0.661 0.313
SPADI
 Preoperative 65.5 ± 16.2 67.3 ± 13.5 68.9 ± 7.5
 2 years 20.6 ± 18.8 20.3 ± 21.2 32.1 ± 17.7
 Follow-up 25.9 ± 21.1 21.9 ± 19.3 33.4 ± 23.7 0.205 0.265 0.770
UCLA
 Preoperative 13.9 ± 4.3 13.8 ± 3.8 13.7 ± 0.6
 2 years 29.0 ± 5.2 29.3 ± 5.8 26.6 ± 6.8
 Follow-up 27.6 ± 6.1 28.7 ± 5.4 25.7 ± 7.0 0.766 0.540 0.373
Constant score (normalized)
 Preoperative 39. 5 ± 15.3 37.3 ± 12.5 32.1 ± 11.2
 2 years 73.7 ± 13.9 73.8 ± 14.3 62.3 ± 15.6
 Follow-up 70.0 ± 15.6 73.9 ± 13.7 63.6 ± 19.6 0.826 0.426 0.523
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Table 5 Quality of  life (QOL) represented by  the Medical Outcomes Short Form 12 (SF-12) total score, physical compo-
nent score (PCS), and mental component score (MCS)











 Preoperative 32.6 ± 6.6 31.4 ± 6.4 24.7 ± 5.7
 2 years 37.6 ± 6.4 36.7 ± 6.9 32.1 ± 6.6
 Follow-up 36.3 ± 7.2 35.9 ± 7.3 30.8 ± 3.9 0.0001 0.714 0.541
SF-12 PCS
 Preoperative 12.9 ± 2.9 11.9 ± 2.9 10.0 ± 2.1
 2 years 15.4 ± 3.4 14.9 ± 3.5 12.3 ± 3.1
 Follow-up 14.8 ± 3.7 14.5 ± 3.6 11.2 ± 2.1 0.0001 0.477 0.910
SF-12 MCS
 Preoperative 19.6 ± 4.2 19.4 ± 4.4 14.6 ± 4.2
 2 years 22.2 ± 3.7 21.8 ± 3.7 19.7 ± 4.0
 Follow-up 21.5 ± 4.2 21.4 ± 4.3 19.6 ± 3.4 0.0001 0.926 0.508
Table 6 Shoulder motion and strength
Values are mean ± SD. Significance is the interaction of time point by obesity status







p (sig) obesity p (sig) surgery type p (sig) interaction
Active motion
External rotation (°)
 Preoperative 8.9 ± 5.5 9.1 ± 5.8 11.6 ± 7.1
 2 years 10.7 ± 6.0 13.4 ± 8.1 13.4 ± 6.1
 Follow-up 10.9 ± 6.2 12.2 ± 6.4 12.9 ± 6.4 0.0001 0.0001 0.021
Elevation (°)
 Preoperative 85.1 ± 32.2 84.1 ± 29.8 79.1 ± 32.7
 2 years 120.1 ± 24.6 124.9 ± 24.6 118.3 ± 36.5
 Follow-up 118.6 ± 28.7 120.6 ± 27.8 115.9 ± 36.8 0.536 0.940 0.734
Passive motion
External rotation (°)
 Preoperative 35.2 ± 23.5 28.3 ± 17.7 29.2 ± 18.6
 2 years 51.7 ± 17.3 51.1 ± 17.5 48.1 ± 18.7
 Follow-up 52.5 ± 18.3 49.1 ± 15.7 52.1 ± 15.1 0.051 0.204 0.171
Elevation
 Preoperative 118.1 ± 30.0 112.5 ± 31.9 106.1 ± 29.9
 2 years 140.2 ± 17.7 145.3 ± 14.9 142.7 ± 19.4
 Follow-up 138.2 ± 20.9 142.4 ± 17.5 145.4 ± 18.7 0.850 0.047 0.121
Maximal weight able to lift
Weight lifted (kg)a
 Preoperative 0.7 ± 1.3 0.4 ± 1.1 0.0
 2 years 1.9 ± 2.0 2.2 ± 2.0 0.9 ± 1.4
 Follow-up 1.6 ± 1.8 2.2 ± 2.2 1.8 ± 2.6 0.301 0.780 0.301
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Recent studies measured shoulder replacement out-
comes in obese patients. First, a case control study of 
obese and non-obese patients (N =  84) with RSA simi-
larly found that obese patients did not achieve the same 
ASES improvement as non-obese controls after sur-
gery (86 vs. 105%) (Pappou et  al. 2014). Pain subscores 
improved similarly in the two patients groups (78–80%), 
but the greatest change occurred in the ASES function 
subscores in the non-obese and obese patients (142 vs. 
89%). Second, a prospective study of patients enrolled in 
a shoulder registry (N =  76) collected preoperative and 
2-year ASES and SF-36 scores, and visual analogue scales 
of pain and fatigue (Li et  al. 2013). Patients were strati-
fied into ‘‘normal’’ weight, overweight, and obese groups 
based on BMI. The ASES scores improved by 108 and 
123% in the normal weight and obese patients, respec-
tively. Improvements on the SF-36 physical and mental 
subscores were less in the obese patients than the normal 
weight patients, however. The obese patients experienced 
2.1–12% improvements in the physical SF-36 subscores 
compared to the normal weight patients, who experi-
enced improvements ranging from 11.3 to 40.2%. Third, 
a study of morbidly obese patients with TSA (N  =  45 
shoulders) found a 53.5% reduction in pain out to an 
average of 4.6  years of follow up (Linberg et  al. 2009). 
These studies and ours suggest that obese patients may 
report improvements in shoulder-related function, but 
potentially less improvement in reported QOL.
Individuals with low and high BMI values can improve 
active elevation, external rotation, and internal rota-
tion abduction and forward flexion after TSA and RSA 
(Constant et  al. 2008; Gupta et  al. 2014). We observed 
improvements in active (external rotation, active eleva-
tion) and passive (external rotation, elevation) ROM 
between morbidly obese, obese, and non-obese patients. 
Shoulder raise strength gains were made across all 
groups, with continued strength gain in the mor-
bidly obese group. Obesity reduces upper body mus-
cle strength and endurance (Cavuoto and Nussbaum 
2014), compromises shoulder ROM as much as 38.9% 
for actions like shoulder abduction (Park et  al. 2010), 
and increases upward scapular rotation during move-
ment (Gupta et al. 2013). The combination of low mus-
cle strength and shoulder ROM negatively impacts the 
ability to perform daily activities. Thus, improvements in 
ROM and strength in obese patients after surgery might 
translate to sustained performance of activities of daily 
living over time (Maier et al. 2014).
Case–control data comparing outcomes between TSA 
and RSA revealed that ASES scores, pain severity, eleva-
tion, abduction, and internal rotation improved similarly 
after the two procedures (Kiet et  al. 2015). After RSA 
and TSA, a significant proportion of patients continue to 
participate in medium or high-demand activities (84 and 
89%, respectively), but there are specific activities that 
people with RSA are unable to do well (Ware et al. 1996). 
Morbidly obese patients may experience unique difficul-
ties with shoulder movements that are not captured with 
current instruments. Development of task inventories 
that may be relevant to an obese person may provide 
researchers and clinicians with better insight into the 
impact of the surgery on shoulder function. Surgeons and 
patients would benefit from discussing functional and 
QOL goals to determine which procedure would yield the 
best results (Schwarzkopf et al. 2013). Here, the morbidly 
obese group’s pain may be more related to degenerative 
disease and less to rotator cuff issues, whereas the non-
obese group’s pain may be more linked with rotator cuff 
arthropathy and acute fracture. The fact that there were 
no differences in adverse events and radiological out-
comes in the three patient groups indicates that obesity 
does not compromise the success of shoulder replace-
ment. Surgical possibilities are open to both procedures, 
even in morbidly obese patients.
To our knowledge, this is the first study to examine the 
mid-term changes in function and patient-reported QOL 
after two shoulder replacement surgery types. Some limi-
tations and strengths deserve comment. First, the patient 
subgroup sizes are different, with the morbidly obese 
subgroup being the smallest size. Based on clinical track-
ing of patient population demographics, we believe that 
this distribution represents the actual proportions of 
patients seen in this tertiary care institution. This study 
collected a battery of standardized assessments, most of 
which were self-report surveys. These surveys were joint-
specific and general, providing a more comprehensive 
assessment of the patient experience. The same investiga-
tors administered the surveys and performed functional 
testing in all patients, minimizing interrater error.
Conclusions
Shoulder replacement procedures improve function and 
QOL outcomes in patients across the BMI spectrum 
out to an average of 5  years. The interactions of obe-
sity status and surgery type for key outcomes were not 
different in the non-obese, obese, and morbidly obese 
patients. Adverse event frequencies and radiological 
outcomes were not higher in obese and morbidly obese 
patients. Morbidly obese patients can achieve meaning-
ful shoulder outcomes and QOL without elevated risk for 
adverse events or worse radiological outcomes over the 
mid-term.
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